Literature DB >> 7887432

Delivery of molecular genetic services within a health care system: time analysis of the clinical workload. The Molecular Genetic Study Group.

L C Surh1, P G Wright, M Cappelli, A Kasaboski, V A Hastings, A G Hunter.   

Abstract

The most recent discoveries in molecular genetics today are rapidly incorporated into clinical practice and have resulted in an unprecedented expansion of medical options. Despite this, the impact of molecular genetics on health care services has yet to be evaluated. In order to begin this assessment, clinical genetic workload was prospectively collected from cases where molecular genetic testing was considered. Participation involved all 16 urban and outreach genetic centers regionalized to service the entire population of 10 million within the Canadian province of Ontario. Molecular genetic testing has been clinically available for > 5 years, as part of a publicly supported genetic network in which there are no direct costs to residents. Cross-sectional data were collected on 1,101 clients from 544 families involving 1,742 clinical actions relating to diseases in which molecular (DNA) tests were considered. Median times per clinical genetic action were as follows: formal counseling (60 min), case review (15 min), phone call (10 min), letter (15 min), specimen arrangement (15 min), and interpretation of molecular test results (10 min). Times varied significantly with the inheritance pattern of the disease, topics involved, and location. For any given genetic case, multiple clinical actions resulted in substantial time spent by the genetic professional. Clerical and administrative times were not captured. Workload unit measurements similar to those currently employed in hospital laboratories may be helpful for predicting the clinical resources and personnel that will be required as the use of molecular genetics by other medical specialties increases.

Mesh:

Substances:

Year:  1995        PMID: 7887432      PMCID: PMC1801167     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Psychological and social consequences of community carrier screening programme for cystic fibrosis.

Authors:  E K Watson; E S Mayall; J Lamb; J Chapple; R Williamson
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

2.  New French genome centre aims to prove that bigger really is better.

Authors:  C Anderson
Journal:  Nature       Date:  1992-06-18       Impact factor: 49.962

3.  The economics of clinical genetics services. II. A time analysis of a medical genetics clinic.

Authors:  B A Bernhardt; J Weiner; E C Foster; J E Tumpson; R E Pyeritz
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

4.  A time analysis of a genetic counseling delivery system.

Authors:  B R Rollnick
Journal:  Birth Defects Orig Artic Ser       Date:  1984

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  Factors contributing to the length of general practice consultations.

Authors:  N V Raynes; V Cairns
Journal:  J R Coll Gen Pract       Date:  1980-08

7.  Prenatal screening for cystic fibrosis.

Authors:  M E Mennie; A Gilfillan; M Compton; L Curtis; W A Liston; I Pullen; D A Whyte; D J Brock
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

8.  Developing shared decision-making programs to improve the quality of health care.

Authors:  J F Kasper; A G Mulley; J E Wennberg
Journal:  QRB Qual Rev Bull       Date:  1992-06

9.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

View more
  4 in total

Review 1.  How to establish a high-risk cancer genetics clinic: limitations and successes.

Authors:  Mary B Daly; Beth Stearman; Agnes Masny; Elaine Sein; Susan Mazzoni
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

2.  Questioning the need for anonymous genetic counseling and testing.

Authors:  W R Uhlmann; D Ginsburg; T D Gelehrter; J Nicholson; E M Petty
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

3.  1999 Presidential Address to the National Society of Genetic Counselors.

Authors:  W R Uhlmann
Journal:  J Genet Couns       Date:  2000-02       Impact factor: 2.537

4.  Workload measurement for molecular genetics laboratory: A survey study.

Authors:  Enrico Tagliafico; Isabella Bernardis; Marina Grasso; Maria Rosaria D'Apice; Cristina Lapucci; Annalisa Botta; Daniela Francesca Giachino; Maria Marinelli; Paola Primignani; Silvia Russo; Ilaria Sani; Manuela Seia; Sergio Fini; Paola Rimessi; Elena Tenedini; Anna Ravani; Maurizio Genuardi; Alessandra Ferlini
Journal:  PLoS One       Date:  2018-11-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.